GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
FRA:GXI - Deutsche Boerse Ag - DE000A0LD6E6 - Common Stock - Currency: EUR
Overall GXI gets a fundamental rating of 4 out of 10. We evaluated GXI against 17 industry peers in the Life Sciences Tools & Services industry. GXI has a medium profitability rating, but doesn't score so well on its financial health evaluation. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
In the past year GXI had a positive cash flow from operations.
Each year in the past 5 years GXI has been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of GXI (1.63%) is worse than 61.11% of its industry peers.
GXI has a Return On Equity (5.20%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 4.57%, GXI perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is in line with the industry average of 6.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.2% | ||
| ROIC | 4.57% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a worse Profit Margin (3.77%) than 61.11% of its industry peers.
GXI's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 8.65%, GXI is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of GXI has grown nicely.
With a Gross Margin value of 28.95%, GXI is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.65% | ||
| PM (TTM) | 3.77% | ||
| GM | 28.95% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GXI is creating some value.
Compared to 1 year ago, GXI has about the same amount of shares outstanding.
GXI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GXI has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.87, we must say that GXI is in the distress zone and has some risk of bankruptcy.
GXI has a Altman-Z score of 0.87. This is amonst the worse of the industry: GXI underperforms 83.33% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that GXI is somewhat dependend on debt financing.
GXI has a Debt to Equity ratio of 0.60. This is comparable to the rest of the industry: GXI outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.87 |
ROIC/WACC0.79
WACC5.77%
2.3 Liquidity
A Current Ratio of 0.61 indicates that GXI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.61, GXI is doing worse than 88.89% of the companies in the same industry.
GXI has a Quick Ratio of 0.61. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
GXI's Quick ratio of 0.34 is on the low side compared to the rest of the industry. GXI is outperformed by 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.34 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased by -0.88% in the last year.
GXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, GXI shows a small growth in Revenue. The Revenue has grown by 4.55% in the last year.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-0.88%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-29.23%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%11.57%
3.2 Future
The Earnings Per Share is expected to grow by 14.16% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.78% on average over the next years. This is quite good.
EPS Next Y12.58%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
EPS Next 5Y14.16%
Revenue Next Year21.4%
Revenue Next 2Y14.56%
Revenue Next 3Y12.32%
Revenue Next 5Y9.78%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
GXI is valuated reasonably with a Price/Earnings ratio of 10.42.
Based on the Price/Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GXI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 7.66, the valuation of GXI can be described as very cheap.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.42 | ||
| Fwd PE | 7.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.92 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GXI's earnings are expected to grow with 15.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y14.26%
EPS Next 3Y15.62%
5. Dividend
5.1 Amount
GXI has a yearly dividend return of 0.08%, which is pretty low.
In the last 3 months the price of GXI has falen by -39.25%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 0.73, GXI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.40, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.08% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
56.16% of the earnings are spent on dividend by GXI. This is a bit on the high side, but may be sustainable.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.16%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
FRA:GXI (6/13/2025, 7:00:00 PM)
46.78
-0.94 (-1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.13%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap1.62B
Analysts83.33
Price Target94.89 (102.84%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.08% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP56.16%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.31%
Min EPS beat(2)17.79%
Max EPS beat(2)18.84%
EPS beat(4)3
Avg EPS beat(4)10.77%
Min EPS beat(4)-2%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.46%
EPS beat(12)8
Avg EPS beat(12)4.54%
EPS beat(16)9
Avg EPS beat(16)2.98%
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.72%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)-0.72%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.13%
PT rev (1m)-0.89%
PT rev (3m)-8.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.42 | ||
| Fwd PE | 7.66 | ||
| P/S | 0.77 | ||
| P/FCF | N/A | ||
| P/OCF | 8.72 | ||
| P/B | 1.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.92 |
EPS(TTM)4.49
EY9.6%
EPS(NY)6.11
Fwd EY13.06%
FCF(TTM)-5.44
FCFYN/A
OCF(TTM)5.36
OCFY11.47%
SpS60.5
BVpS43.79
TBVpS-7.82
PEG (NY)0.83
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.2% | ||
| ROCE | 6.16% | ||
| ROIC | 4.57% | ||
| ROICexc | 4.87% | ||
| ROICexgc | 13.87% | ||
| OM | 8.65% | ||
| PM (TTM) | 3.77% | ||
| GM | 28.95% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexcg growth 3Y-17.1%
ROICexcg growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score3
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.29 | ||
| Cap/Depr | 170.95% | ||
| Cap/Sales | 17.86% | ||
| Interest Coverage | 2.93 | ||
| Cash Conversion | 46.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.34 | ||
| Altman-Z | 0.87 |
F-Score3
WACC5.77%
ROIC/WACC0.79
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.88%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-29.23%
EPS Next Y12.58%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
EPS Next 5Y14.16%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%11.57%
Revenue Next Year21.4%
Revenue Next 2Y14.56%
Revenue Next 3Y12.32%
Revenue Next 5Y9.78%
EBIT growth 1Y-15.63%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year139.92%
EBIT Next 3Y43.59%
EBIT Next 5Y28.57%
FCF growth 1Y-179.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.34%
OCF growth 3Y4.26%
OCF growth 5Y4.49%